1. Home
  2. ODC vs ERAS Comparison

ODC vs ERAS Comparison

Compare ODC & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil-Dri Corporation Of America

ODC

Oil-Dri Corporation Of America

HOLD

Current Price

$71.55

Market Cap

895.7M

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$17.86

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODC
ERAS
Founded
1941
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
895.7M
5.5B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
ODC
ERAS
Price
$71.55
$17.86
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$12.08
AVG Volume (30 Days)
47.1K
5.0M
Earning Date
03-11-2026
05-12-2026
Dividend Yield
1.14%
N/A
EPS Growth
50.45
36.23
EPS
1.69
N/A
Revenue
$485,572,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.70
N/A
Revenue Growth
10.97
N/A
52 Week Low
$41.37
$1.06
52 Week High
$73.46
$18.20

Technical Indicators

Market Signals
Indicator
ODC
ERAS
Relative Strength Index (RSI) 71.52 63.75
Support Level $58.40 $1.72
Resistance Level N/A $18.20
Average True Range (ATR) 1.85 1.30
MACD 0.82 0.01
Stochastic Oscillator 86.87 88.45

Price Performance

Historical Comparison
ODC
ERAS

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: